Comparison of Miglitol and Acarbose in Japanese patient with type 2 diabetes by using continuous glucose monitoring (CGM).

Trial Profile

Comparison of Miglitol and Acarbose in Japanese patient with type 2 diabetes by using continuous glucose monitoring (CGM).

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 20 Jun 2009

At a glance

  • Drugs Acarbose (Primary) ; Miglitol (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms MAJOR
  • Most Recent Events

    • 20 Jun 2009 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 23 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top